プロゲステロンの世界市場は、2022年に約11億5,720万米ドルと評価され、予測期間の2023年から2030年には13.3％以上の健全な成長率で成長すると予測されています。プロゲステロンは、主に排卵後に卵巣で産生される女性ホルモンです。子宮を妊娠に備えさせ、健康な妊娠を維持する上で重要な役割を果たしています。プロゲステロンは月経周期の調整にも役立ち、乳房組織の発達にも関与しています。また、生理不順、不妊症、更年期障害など、さまざまな症状の治療薬としても使用されます。更年期女性のホルモン補充療法の一環として処方されることも多くなっています。プロゲステロン市場は、子宮内膜がんの罹患率の増加、女性不妊症や乳がんの症例の増加などの要因により拡大しています。
妊娠中は、プロゲステロンのレベルが著しく上昇し、子宮の早期収縮を防ぐのに役立ちます。閉経後は、エストロゲンとともにプロゲステロンの産生が減少し、ほてり、膣の乾燥、骨量減少などの症状が現れます。ここ数十年の間に、その有病率は徐々に増加しています。米国がん協会によると、2023年には新たに約66,200例の子宮体がんが診断されるとされています。さらに、アメリカでは約13,030人の女性が子宮体部のがんで死亡するでしょう。さらに、同年に浸潤性子宮頸がんが新たに約13,960例診断され、4,310人の女性が子宮頸がんで死亡すると予測されています。本市場を牽引するもうひとつの重要な要素は、女性の不妊症と乳がんの症例が増加していることです。世界保健機関（WHO）によると、2020年には世界で230万人の女性が乳がんと診断され、685,000人が死亡しています。また、米国臨床腫瘍学会によると、2023年にはアメリカで297,790人の女性が浸潤性乳がんと診断され、55,720人の女性が非浸潤性乳がんと診断されると推定されています。また、製剤の進歩や医療業界における技術の進歩は、予測期間を通じて市場に有利な成長見通しをもたらすでしょう。しかし、ホルモン療法の利用可能性に関する認識不足が、2023年から2030年の予測期間を通じて市場の成長を阻害しています。
世界のプロゲストロン市場調査の対象となる主要地域には、アジア太平洋、北アメリカ、ヨーロッパ、ラテンアメリカ、中東およびアフリカが含まれます。2022年の市場は、乳がん患者数の増加により北アメリカが優位を占めました。Breastcancer.orgによると、2022年にはアメリカで新たに287,850例の浸潤性乳がんが女性に診断され、51,400例の非浸潤性乳がんが新たに診断されると推定されています。アジア太平洋地域は、予測期間中に大きく成長すると予想されます。これは、対象人口の増加や、市場空間における政府や非営利団体の積極的な参加などの要因によるものです。
この調査の目的は、近年のさまざまなセグメントおよび国の市場規模を定義し、今後数年間の市場規模を予測することです。この報告書は、調査に参加している国の業界の定性的および定量的側面の両方を組み込むように設計されています。
このレポートは、市場の将来の成長を定義する推進要因や課題などの重要な側面に関する詳細情報も提供します。さらに、競争環境と主要企業の製品提供の詳細な分析とともに、利害関係者が投資できるミクロ市場における潜在的な機会も組み込まれています。
目次
Table of Contents
Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Million)
1.2.1. Progesterone Market, by Region, 2020-2030 (USD Million)
1.2.2. Progesterone Market, by Type, 2020-2030 (USD Million)
1.2.3. Progesterone Market, by Mode of Delivery, 2020-2030 (USD Million)
1.2.4. Progesterone Market, by Application, 2020-2030 (USD Million)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Progesterone Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Industry Evolution
2.2.2. Scope of the Study
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Progesterone Market Dynamics
3.1. Progesterone Market Impact Analysis (2020-2030)
3.1.1. Market Drivers
3.1.1.1. Increasing incidence of endometrial cancer
3.1.1.2. Growing cases of female infertility and breast cancer
3.1.2. Market Challenges
3.1.2.1. Lack of awareness regarding the availability of hormone therapy
3.1.3. Market Opportunities
3.1.3.1. Advancements in Formulation
3.1.3.2. Technological Advancements in the Medical Industry
Chapter 4. Global Progesterone Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Porter’s 5 Force Impact Analysis
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.3.5. Environmental
4.3.6. Legal
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. COVID-19 Impact Analysis
4.7. Disruptive Trends
4.8. Industry Expert Perspective
4.9. Analyst Recommendation & Conclusion
Chapter 5. Global Progesterone Market, by Type
5.1. Market Snapshot
5.2. Global Progesterone Market by Type, Performance - Potential Analysis
5.3. Global Progesterone Market Estimates & Forecasts by Type 2020-2030 (USD Million)
5.4. Progesterone Market, Sub Segment Analysis
5.4.1. Natural Progesterone
5.4.2. Synthetic Progesterone
Chapter 6. Global Progesterone Market, by Mode of Delivery
6.1. Market Snapshot
6.2. Global Progesterone Market by Mode of Delivery, Performance - Potential Analysis
6.3. Global Progesterone Market Estimates & Forecasts by Mode of Delivery 2020-2030 (USD Million)
6.4. Progesterone Market, Sub Segment Analysis
6.4.1. Injectable
6.4.2. Suspended Form
6.4.3. Oral
Chapter 7. Global Progesterone Market, by Application
7.1. Market Snapshot
7.2. Global Progesterone Market by Application, Performance - Potential Analysis
7.3. Global Progesterone Market Estimates & Forecasts by Application 2020-2030 (USD Million)
7.4. Progesterone Market, Sub Segment Analysis
7.4.1. Regulation of the Menstrual Cycle
7.4.2. Dysfunctional Uterine Bleeding
7.4.3. Endometrial Cancer
7.4.4. Contraception
7.4.5. Hyperplastic Precursor Lesions
Chapter 8. Global Progesterone Market, Regional Analysis
8.1. Top Leading Countries
8.2. Top Emerging Countries
8.3. Progesterone Market, Regional Market Snapshot
8.4. North America Progesterone Market
8.4.1. U.S. Progesterone Market
8.4.1.1. Type breakdown estimates & forecasts, 2020-2030
8.4.1.2. Mode of Delivery breakdown estimates & forecasts, 2020-2030
8.4.1.3. Application breakdown estimates & forecasts, 2020-2030
8.4.2. Canada Progesterone Market
8.5. Europe Progesterone Market Snapshot
8.5.1. U.K. Progesterone Market
8.5.2. Germany Progesterone Market
8.5.3. France Progesterone Market
8.5.4. Spain Progesterone Market
8.5.5. Italy Progesterone Market
8.5.6. Rest of Europe Progesterone Market
8.6. Asia-Pacific Progesterone Market Snapshot
8.6.1. China Progesterone Market
8.6.2. India Progesterone Market
8.6.3. Japan Progesterone Market
8.6.4. Australia Progesterone Market
8.6.5. South Korea Progesterone Market
8.6.6. Rest of Asia Pacific Progesterone Market
8.7. Latin America Progesterone Market Snapshot
8.7.1. Brazil Progesterone Market
8.7.2. Mexico Progesterone Market
8.8. Middle East & Africa Progesterone Market
8.8.1. Saudi Arabia Progesterone Market
8.8.2. South Africa Progesterone Market
8.8.3. Rest of Middle East & Africa Progesterone Market
Chapter 9. Competitive Intelligence
9.1. Key Company SWOT Analysis
9.1.1. Company 1
9.1.2. Company 2
9.1.3. Company 3
9.2. Top Market Strategies
9.3. Company Profiles
9.3.1. Estrellas Life Sciences Private Ltd
9.3.1.1. Key Information
9.3.1.2. Overview
9.3.1.3. Financial (Subject to Data Availability)
9.3.1.4. Product Summary
9.3.1.5. Recent Developments
9.3.2. Bionpharma Inc.
9.3.3. Sofgen Pharmaceuticals
9.3.4. Teva Pharmaceuticals Industries Ltd
9.3.5. Virtus Pharmaceuticals Llc,
9.3.6. Blubell Pharma Group Company
9.3.7. Aquatic Remedies Pvt. Ltd.
9.3.8. Intas Pharmaceuticals Ltd.
9.3.9. Shanghai Yijing Industrial Co ltd
9.3.10. Wuhan Honor Bio-Pharm Co., Ltd
Chapter 10. Research Process
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes
10.3. Research Assumption
List of Tables
TABLE 1. Global Progesterone Market, report scope
TABLE 2. Global Progesterone Market estimates & forecasts by Region 2020-2030 (USD Million)
TABLE 3. Global Progesterone Market estimates & forecasts by Type 2020-2030 (USD Million)
TABLE 4. Global Progesterone Market estimates & forecasts by Mode of Delivery 2020-2030 (USD Million)
TABLE 5. Global Progesterone Market estimates & forecasts by Application 2020-2030 (USD Million)
TABLE 6. Global Progesterone Market by segment, estimates & forecasts, 2020-2030 (USD Million)
TABLE 7. Global Progesterone Market by region, estimates & forecasts, 2020-2030 (USD Million)
TABLE 8. Global Progesterone Market by segment, estimates & forecasts, 2020-2030 (USD Million)
TABLE 9. Global Progesterone Market by region, estimates & forecasts, 2020-2030 (USD Million)
TABLE 10. Global Progesterone Market by segment, estimates & forecasts, 2020-2030 (USD Million)
TABLE 11. Global Progesterone Market by region, estimates & forecasts, 2020-2030 (USD Million)
TABLE 12. Global Progesterone Market by segment, estimates & forecasts, 2020-2030 (USD Million)
TABLE 13. Global Progesterone Market by region, estimates & forecasts, 2020-2030 (USD Million)
TABLE 14. Global Progesterone Market by segment, estimates & forecasts, 2020-2030 (USD Million)
TABLE 15. Global Progesterone Market by region, estimates & forecasts, 2020-2030 (USD Million)
TABLE 16. U.S. Progesterone Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 17. U.S. Progesterone Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 18. U.S. Progesterone Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 19. Canada Progesterone Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 20. Canada Progesterone Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 21. Canada Progesterone Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 22. UK Progesterone Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 23. UK Progesterone Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 24. UK Progesterone Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 25. Germany Progesterone Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 26. Germany Progesterone Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 27. Germany Progesterone Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 28. France Progesterone Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 29. France Progesterone Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 30. France Progesterone Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 31. Italy Progesterone Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 32. Italy Progesterone Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 33. Italy Progesterone Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 34. Spain Progesterone Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 35. Spain Progesterone Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 36. Spain Progesterone Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 37. RoE Progesterone Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 38. RoE Progesterone Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 39. RoE Progesterone Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 40. China Progesterone Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 41. China Progesterone Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 42. China Progesterone Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 43. India Progesterone Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 44. India Progesterone Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 45. India Progesterone Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 46. Japan Progesterone Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 47. Japan Progesterone Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 48. Japan Progesterone Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 49. South Korea Progesterone Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 50. South Korea Progesterone Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 51. South Korea Progesterone Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 52. Australia Progesterone Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 53. Australia Progesterone Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 54. Australia Progesterone Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 55. RoAPAC Progesterone Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 56. RoAPAC Progesterone Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 57. RoAPAC Progesterone Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 58. Brazil Progesterone Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 59. Brazil Progesterone Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 60. Brazil Progesterone Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 61. Mexico Progesterone Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 62. Mexico Progesterone Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 63. Mexico Progesterone Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 64. RoLA Progesterone Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 65. RoLA Progesterone Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 66. RoLA Progesterone Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 67. Saudi Arabia Progesterone Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 68. South Africa Progesterone Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 69. RoMEA Progesterone Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 70. List of secondary sources, used in the study of global Progesterone Market
TABLE 71. List of primary sources, used in the study of global Progesterone Market
TABLE 72. Years considered for the study
TABLE 73. Exchange rates considered
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
List of figures
FIG 1. Global Progesterone Market, research methodology
FIG 2. Global Progesterone Market, Market estimation techniques
FIG 3. Global Market size estimates & forecast methods
FIG 4. Global Progesterone Market, key trends 2022
FIG 5. Global Progesterone Market, growth prospects 2023-2030
FIG 6. Global Progesterone Market, porters 5 force model
FIG 7. Global Progesterone Market, pest analysis
FIG 8. Global Progesterone Market, value chain analysis
FIG 9. Global Progesterone Market by segment, 2020 & 2030 (USD Million)
FIG 10. Global Progesterone Market by segment, 2020 & 2030 (USD Million)
FIG 11. Global Progesterone Market by segment, 2020 & 2030 (USD Million)
FIG 12. Global Progesterone Market by segment, 2020 & 2030 (USD Million)
FIG 13. Global Progesterone Market by segment, 2020 & 2030 (USD Million)
FIG 14. Global Progesterone Market, regional snapshot 2020 & 2030
FIG 15. North America Progesterone Market 2020 & 2030 (USD Million)
FIG 16. Europe Progesterone Market 2020 & 2030 (USD Million)
FIG 17. Asia Pacific Progesterone Market 2020 & 2030 (USD Million)
FIG 18. Latin America Progesterone Market 2020 & 2030 (USD Million)
FIG 19. Middle East & Africa Progesterone Market 2020 & 2030 (USD Million)
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
